Category:

Non-Life

Norway says no link between vaccine and post-jab deaths

The Norwegian Medicines Agency said last week that normal side effects from messenger RNA vaccines, such as fever and nausea, “may have contributed to a fatal outcome in some frail patients.”

A number of countries, including Norway’s neighbours Denmark, Finland, Iceland and Sweden, have reported post-vaccination deaths but no direct links to the vaccine have been established.

read more

Allianz Risk Barometer 2021: Covid-19 trio tops global and Asia Pacific business risks

“The Allianz Risk Barometer 2021 is clearly dominated by the Covid-19 trio of risks. Business interruption, pandemic and cyber are strongly interlinked, demonstrating the growing vulnerabilities of our highly globalized and connected world,” says Joachim Müller, CEO of AGCS.

“The coronavirus pandemic is a reminder that risk management and business continuity management need to further evolve in order to help businesses prepare for, and survive, extreme events. While the pandemic continues to have a firm grip on countries around the world, we also have to ready ourselves for more frequent extreme scenarios, such as a global-scale cloud outage or cyber-attack, natural disasters driven by climate change or even another disease outbreak,” he said.

read more

UK begins major trial for new inhaler-based Covid-19 treatment

“We need treatments as well as vaccines to fight highly pathogenic viruses such as SARS-CoV-2 [Covid-19]. Development of treatments like ours will remain necessary in cases where vaccines are not effective, for those who do not get vaccinated, and in case the virus mutates to the point where vaccines become less effective,” said Richard Marsden, CEO of Synairgen.

read more

Pfizer vaccine worries Norway as 29 elderly people die after taking shot

Official reports of allergic reactions have been rare as governments rush to roll out vaccines to try to contain the global pandemic. U.S. authorities reported 21 cases of severe allergic reactions from Dec. 14-23 after administration of about 1.9 million initial doses of the Pfizer vaccine. The first Europe-wide safety report on the Pfizer-BioNTech vaccine is due to be published at the end of January.

read more

Insurers expect to settle over £1.8bn in Covid-19 related UK claims including BI policies

Today’s ruling had other bad news for insurers. Under the original judgement, cover for BI losses due to business closures during lockdown would have been based on a strict definition of lockdown, when closures were mandatory. The Court decided that this interpretation was too narrow and that cover should include closure instructions from a public authority, even if not backed by the force of law.
Customers who have made claims that are affected by the test case will be contacted by their insurer to discuss what the judgment means for their claim. All valid claims will be settled as soon as possible and in many cases the process of settling claims has begun, said UK’s Association of British Insurers.

read more